相关实验视频

Updated: Jan 13, 2026

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Published on: October 13, 2023

抗药物诱导的-维生素D代谢障碍:使用关联规则挖掘技术的行为分析

Pradeep K Dabla¹, Kamal Upreti², Divakar Singh³

¹Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, Associated Maulana Azad Medical College, New Delhi 110002, Delhi, India. pradeep_dabla@yahoo.com.

World journal of experimental medicine

|January 12, 2026

概括

这项研究发现,使用多种抗药物 (AED) 显著降低维生素D和水平,增加患者的骨健康风险. 协会规则挖掘揭示了多疗法.

科学领域:

神经学神经学
生物化学生物化学
药理学药理学是指药理学的学科.

背景情况:

服用抗药物 (AED) 的患者面临骨健康的风险,原因是可能对维生素D和代谢产生影响.
协会规则挖掘 (ARM) 是一种数据分析技术,能够识别大型数据集中的模式和相关性,包括患者信息.

研究的目的:

研究AEDs对代谢和患者维生素D水平的影响.
探索ARM在识别AED,患者特征和骨健康指标之间的关系方面的实用性.

主要方法:

协会规则挖掘 (ARM) 用于分析来自150名患者的数据,分为三个组,根据所接收的AED数量 (1,2,或>2).
测量了包括性酸酶,电离,总,,维生素D和副甲状腺激素在内的生化标志物.
患者数据包括人口统计,类型和AED治疗的持续时间.

主要成果:

多疗法 (两种以上的AED) 与单疗法或双疗法相比,与显著降低的和维生素D水平有关.
在接受多疗法的患者中观察到性酸酶和的水平升高.
发现性别不平衡 (60%男性),这可能会限制女性患者发现的概括性.

结论:

协会规则挖矿发现了年龄,性别和多疗法对使用抗药物的患者甲状腺激素水平的潜在影响.
使用AED的多疗法似乎对和维生素D水平产生负面影响,突出显示需要对这些患者的骨健康进行监测.

关键词:

抗药物抗药物抗药物协会规则采矿采矿规则是一种病.热点是一个热点.交易和新陈代谢.

更多相关视频

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

相关概念视频

Antiepileptic Drugs: Calcium Channel Blockers

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...